239 related articles for article (PubMed ID: 31056310)
1. Low antimüllerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle-stimulating hormone and AMH are discordant.
Ligon S; Lustik M; Levy G; Pier B
Fertil Steril; 2019 Jul; 112(1):73-81.e1. PubMed ID: 31056310
[TBL] [Abstract][Full Text] [Related]
2. Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
Tal R; Seifer DB; Wantman E; Baker V; Tal O
Fertil Steril; 2018 Feb; 109(2):258-265. PubMed ID: 29331235
[TBL] [Abstract][Full Text] [Related]
3. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
Seifer DB; Tal O; Wantman E; Edul P; Baker VL
Fertil Steril; 2016 Feb; 105(2):385-93.e3. PubMed ID: 26515380
[TBL] [Abstract][Full Text] [Related]
4. Retrospective study of ovarian reaction and fertility in women with discordant antimullerian hormone and follicle-stimulating hormone/luteinizing hormone ratios during in vitro fertilization.
Wang J; Lv Y; Wang X; Zhu G; Zhao F
J Obstet Gynaecol Res; 2023 Mar; 49(3):966-972. PubMed ID: 36734373
[TBL] [Abstract][Full Text] [Related]
5. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
[TBL] [Abstract][Full Text] [Related]
6. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
Nyboe Andersen A; Nelson SM; Fauser BC; García-Velasco JA; Klein BM; Arce JC;
Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian Hormone and Follicle-Stimulating Hormone Are Poor Independent Predictors of Live Birth After Assisted Reproductive Technology.
Siegel DR; Grau L; Sammel M; Nel-Themaaat L; Santoro N; Polotsky AJ
Reprod Sci; 2023 Apr; 30(4):1316-1323. PubMed ID: 36194358
[TBL] [Abstract][Full Text] [Related]
8. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
Hamdine O; Eijkemans MJC; Lentjes EGW; Torrance HL; Macklon NS; Fauser BCJM; Broekmans FJ
Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
[TBL] [Abstract][Full Text] [Related]
11. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study.
Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ
Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952
[TBL] [Abstract][Full Text] [Related]
12. High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers.
Leader B; Hegde A; Baca Q; Stone K; Lannon B; Seifer DB; Broekmans F; Baker VL
Fertil Steril; 2012 Oct; 98(4):1037-42. PubMed ID: 22771028
[TBL] [Abstract][Full Text] [Related]
13. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.
Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC
Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276
[TBL] [Abstract][Full Text] [Related]
15. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.
Bishop LA; Richter KS; Patounakis G; Andriani L; Moon K; Devine K
Fertil Steril; 2017 Dec; 108(6):980-987. PubMed ID: 29202975
[TBL] [Abstract][Full Text] [Related]
16. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
Magnusson Å; Nilsson L; Oleröd G; Thurin-Kjellberg A; Bergh C
Hum Reprod; 2017 Apr; 32(4):811-819. PubMed ID: 28175316
[TBL] [Abstract][Full Text] [Related]
17. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
Mutlu MF; Erdem M; Erdem A; Yildiz S; Mutlu I; Arisoy O; Oktem M
J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
[TBL] [Abstract][Full Text] [Related]
18. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
[TBL] [Abstract][Full Text] [Related]
19. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
20. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]